Background
Polycyclic aromatic hydrocarbons (PAHs) were the first discovered environmental pollutants and carcinogens; as such, they were suggested to be controlled with high priority by the United States Environmental Protection Agency (USEPA). PAHs are widely found in the air, food and drinking water. The metabolic end product of PAHs in the human body is 7,8-dihydrodiol-9.10-epoxide benzo [a] pyrene (BPDE), which has the ability to covalently bind to the nucleophilic sites (outside amino terminals of guanine) of DNA to form PAH-DNA adducts, thus inducing DNA damage, gene mutations and carcinogenesis, processes related to tumor formation. These findings indicate that PAHs are indirect carcinogens. Benzo (a) pyrene is considered a PAH representative, as a chemical carcinogen with high carcinogenicity. On the other hand, PAHs are important environmental pollutants that can suppress the immune function. Studies by Szczeklik et al. have shown that exposure to PAHs results in immune inhibition, with reduced serum IgG and IgA levels and increased IgE and IgM amounts in coke oven workers. IL-2 is a T cell growth factor, which enhances the cytotoxic activity of T cells; IL-6 is a multi-effect cytokine produced by endothelial cells, monocytes/macrophages, and lymphoid cells. IL-6 promotes B cell proliferation and differentiation, inducing antibody secretion. However, the effect of single PAHs such as anthracene, benzo (a) pyrene, and benzo [G, H, I] perylene, on IL-2 and IL-6 production/secretion is still largely unknown.
Material and Methods

Material
A total of 120 SPF Kun Ming mice (Gansu College Experimental Animal Center, SCXK (Gan) 2011-0001-0001331) at 1:1 sex ratio (20±2g) were housed in a standard rodent room (temperature 18-29ºC, diurnal temperature £3ºC and relative humidity of 40-70%). Anthracene, benzo (a) pyrene and benzo [G, H, I] perylene, were purchased from AccuStandard (USA). Dimethyl sulfoxide (DMSO) and ether were purchased from Shanghai No. 1 Biochemical Pharmaceutical Co., Ltd (China).
The animal equipment was purchased from Lanzhou City medical Devices Corporation (China). IL-2 and IL-6 ELISA assay kits were purchased from R&D Company, Inc. (USA).
Methods
Establishment of animal models
The animal models were established as described previously. Briefly, 20 mice were used for preliminary experiments to determine suitable dosages for PAHs (EU 2005 standard). Then, 100 mice (1:1 sex ratio, 20±2 g) were randomly divided into five groups (n=20) to be intraperitoneally injected with 10 daily doses of DMSO (control), anthracene (50 mg/kg), benzo-(a)-pyrene (10 mg/kg), benzo-(a)-pyrene (20 mg/kg) and benzo-[G, H, I])-perylene (5 mg/kg), respectively. All test articles were administered in 0.1 mL DMSO/gram body weight. Animals were examined once daily for three months.
Sample collection and assessment
After anesthesia with ether, mouse blood was collected from the femoral artery and Verify. Then, serum IL-2 and IL-6 levels were determined following the manufacturer's instructions. Moreover, liver, spleen, kidney, pancreas, stomach and lung were collected from each animal upon euthanasia. Then, the tissue samples were fixed with formalin, conventionally embedded and sliced. After hematoxylin and eosin (H&E) staining, slides were analyzed by microscopy.
Statistical analysis
Statistical analysis was carried out using the SPSS 11.5 software (SPSS, USA). P<0.05 was considered statistically significant.
Results
Tumorigenic effects of PAHs
During the study, 7 mice died due to toxicity. Cancer incidences for the various groups are summarized in Table 1 and Figures 1-3 . The incidences of precancerous lesions were significantly higher in treatment groups compared with control animals (P<0.05). Treatment with benzo (a) pyrene at 20 mg/kg significantly increased the incidences of cancer and precancerous lesions in the stomach compared with the lower dose of 10 mg/kg. No obvious damages were observed in the lung for either treatment groups. Table 2 summarizes the serum levels of IL-2 and IL-6 in each group. They were significantly lower in the treatment groups compared with control values (p<0.05); no significant differences were obtained among treatment groups (p>0.05).
Effect of PAHs on IL-2 and IL-6 levels
Discussion
PAHs mainly originate from the incomplete combustion of organics, and are easily produced by human activities. PAHs were the first discovered environmental pollutants and carcinogens.
Following entry in the body, most PAHs produce a variety of intermediates and end products after mixed function oxidase metabolism. Some of their metabolites can covalently bind to DNA and form PAH-DNA adducts, thus inducing DNA damage and gene mutations, and even promoting carcinogenesis. Benzo(a)pyrene (BaP) is a pro-carcinogen, which can cause DNA damage: BaP is oxidized by cytochrome P450 enzymes (such as CYPIA1) in the microsomes of liver and lung 
Conclusions
Here, we showed that IL-2 and IL-6 levels in treatment groups were significantly lower than control values (P<0.01), suggesting an inhibition of the immune function by PAHs. However, further studies are warranted to reveal the underlying mechanisms of these effects.
